No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
AU Stock MarketDetailed Quotes
TLRA Talaria Global Equity ETF
- 4.930
- +0.040+0.82%
20min DelayNot Open Jul 23 16:00 AET
4.930High4.910Low
4.930High4.910Low669.52KVolume4.920Open4.890Pre Close3.30MTurnover5.03052wk High0.17%Turnover Ratio387.41MShares4.59552wk Low--EPS TTM1.91BFloat Cap5.030Historical High--P/E (Static)387.41MShs Float3.679Historical Low--EPS LYR0.41%Amplitude0.38Dividend TTM--P/B1Lot Size7.73%Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
Viiv's Dovato as Effective as Gilead' Biktarvy for HIV but With Less Weight Gain
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
Breaking Down Gilead Sciences: 10 Analysts Share Their Views
Alvotech Launches First Biosimilar of J&J's Stelara in Europe
Gilead Sciences Analyst Ratings